3 in 5 US adults projected to have CVD by 2050, with a price tag of $1.8T—can cardiologists ‘turn the tide’?

At least 61% of adults in the United States are expected to have cardiovascular disease (CVD) by 2050, according to new data published by the American Heart Association (AHA). CVD-related costs during that time, meanwhile, could reach up to $1.8 trillion.

Two new AHA presidential advisories, both published in Circulation, explore these findings at length. One advisory is focused on the risk factors associated with CVD and stroke, including what cardiologists and other healthcare professionals can do to help reach patients as early as possible.[1] The other examines the economic burden of CVD and stroke, which is expected to “increase substantially in the coming decades.”[2]

“Supported by efforts led by the AHA, death rates from heart disease have been cut in half in the past 100 years,” Karen E. Joynt Maddox, MD, MPH, a cardiologist and health policy researcher at Washington University School of Medicine in St. Louis and volunteer chair of the advisories’ writing groups, said in a prepared statement. “Deaths from stroke have been cut by a third since the creation of the American Stroke Association in 1998. Yet, these are still leading causes of death and disability in the U.S. So, in analyzing the data for these advisories, we set out to learn just what we may expect over the next 30 years, and to identify specific issues that need to be addressed to ensure that we continue our forward progress. Armed with these findings, we can take steps to turn the tide on this dire forecast.”

“It is crucial to quantify the full burden of cardiovascular disease so we can better inform the policies and community-level and health system interventions needed to change this current path,” added Nancy Brown, AHA CEO. “We recognize that the landscape of cardiovascular health will change over the next three decades because of the coming tsunami of rising health care costs, an older population living longer and increasing numbers of people from under-resourced populations. The findings of these important advisories predict a dire human and economic toll from heart disease and stroke if changes are not made. However, this does not have to be the reality of our future.”

Diving deeper into the data, rates of high blood pressure, stroke, obesity and diabetes are all projected to increase significantly in the United States in the coming years. Obesity, for instance, could impact more than 180 million people by 2050.

Obesity among children is one area where the projections are especially troubling. While the obesity was seen in 20.6% of children between the ages of 2 and 19 in 2020, that is expected to hit 33% by 2050.

The AHA projections also show that racial and ethnic disparities continue to be a major issue throughout the country.

Black adults have higher projected rates of hypertension, diabetes and obesity than any other group, for example, in addition to the highest projected prevalence of inadequate sleep and poor diet. Asian adults, meanwhile, have the highest projected prevalence of inadequate physical activity.

“We found larger increases in the prevalence of CVD and risk factors, and in the number of people with these conditions, among people from racially and ethnically diverse backgrounds,” Joynt Maddox said. “Some of this is due to demographic shifts in the U.S., with projections suggesting that Asian and Hispanic populations will nearly double by 2060. However, much of the inequity we see in CVD and risk factors remains attributed to systemic racism, as well as socioeconomic factors and access to care.”

Encouraging news in the face of rising cardiovascular rates

Fortunately, evidence suggests that healthy lifestyles are starting to become more popular among the country’s adults. According to AHA projections, inadequate physical activity and cigarette smoking rates are both expected to fall in the years ahead. Even poor diets are projected to become slightly less common, dropping from 52.5% of U.S. adults to 51.1%, but there is still clearly plenty of work to do.

“It is extremely promising to see these health behaviors improve, as it indicates a movement by individuals taking control of their health and making positive change,” said Joseph C. Wu, MD, PhD, volunteer president of the AHA. “I’m especially pleased to see smoking rates drop substantially, as tobacco addiction is one of the deadliest factors impacting cardiovascular disease over the past century.”

Considering the high costs of cardiovascular disease

As CVD risk factors become more common, it makes sense that the economic impact of CVD is going to grow as well. The projected price tag of $1.8 trillion includes both direct and indirect healthcare costs related to the management and treatment of CVD.

Direct costs alone could increase by $393 billion from 2020 to 2050. In addition, costs associated with stroke care are expected to play a key role in this ongoing trend—they could rise up to 535% in the next few decades.

How cardiologists and other healthcare providers can bring about serious change

The authors of the two advisories emphasized that it is not too late to change these trends and reduce the projected long-term impact of CVD in the United States. If cardiologists and other members of the heart team can work together to reduce rates of high blood pressure, high cholesterol, diabetes and obesity, CVD and stroke rates could be much than current projections suggest.

It's not exclusively about reducing risk factors, however, scientific research is another key piece of the puzzle.

“While our forecast analysis was not able to take it into account, the recent approval of glucagon-like peptide 1 agonists and related drugs to treat diabetes and obesity may lead to a sea change in our medical approach to these conditions,” Wu said. “The next life-changing, life-saving treatment may be developing in a petri dish right now. We must redouble our efforts and support for funding cutting-edge research that may lead to approaches so innovative they don’t yet exist even in our imagination.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.